NF-κB信号介导的WNK-SPAK-NKCC1级联激活加重血管紧张素II高血压小鼠的卒中结局
在血管紧张素II(ang II)输注的高血压小鼠卒中模型中,卒中后24小时脑内WNK(1、2、4亚型)、SPAK/OSR1和NKCC1蛋白增加2至5倍,与皮质神经元磷酸化NF-κB核转位增加相关(Pearson r=0.77,P<0.005)。NF-κB抑制剂TAT-NBD减弱该级联上调;SPAK抑制剂ZT-1a减少复合物激活、脑病灶大小和神经功能缺损,且不改变血压和脑血流。
要点
- 高血压合并卒中时,ang II通过NF-κB转录激活上调脑WNK-SPAK-NKCC1级联。
- SPAK抑制剂ZT-1a减轻ang II高血压小鼠卒中后病灶和神经功能缺损,不影响血压和脑血流。
- 脑WNK-SPAK-NKCC1复合物可能是高血压合并卒中的治疗靶点。
核心结论
- ang II诱导的NF-κB转录活性刺激上调脑WNK-SPAK-NKCC1级联,导致缺血性卒中结局加重,提示脑WNK-SPAK-NKCC1复合物是高血压合并卒中的治疗靶点。
研究设计与样本
- 盐水或ang II输注的C57BL/6J雄性小鼠接受大脑中动脉远端分支永久闭塞诱导卒中,随机接受溶媒二甲基亚砜/PBS(2 mL/kg体重/天,腹腔注射)、新型SPAK抑制剂ZT-1a(5 mg/kg/天,腹腔注射)或NF-κB抑制剂TAT-NBD(20 mg/kg/天,腹腔注射),检测脑NF-κB和WNK-SPAK-NKCC1级联激活及缺血性卒中结局。
主要发现
- ang II输注的高血压小鼠卒中后24小时脑内WNK(1、2、4亚型)、SPAK/OSR1和NKCC1蛋白增加2至5倍,与皮质神经元磷酸化NF-κB蛋白核转位增加相关(Pearson r=0.77,P<0.005)。
- WNK-SPAK-NKCC1级联蛋白上调源于NF-κB在Wnk1、Wnk2、Wnk4、Spak和Nkcc1基因启动子上招募增加,并被NF-κB抑制剂TAT-NBD减弱。
- 卒中后给予SPAK抑制剂ZT-1a显著减少ang II高血压小鼠的WNK-SPAK-NKCC1复合物激活、脑病灶大小和神经功能缺损,且不影响血压和脑血流。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Worsened stroke outcomes with hypertension comorbidity are insensitive to blood pressure-lowering therapies. In an experimental stroke model with comorbid hypertension, we investigated causal roles of ang II (angiotensin II)-mediated stimulation of the brain WNK (with no lysine [K] kinases)-SPAK (STE20/SPS1-related proline/alanine-rich kinase)-NKCC1 (Na-K-Cl cotransporter) complex in worsened outcomes. METHODS: Saline- or ang II-infused C57BL/6J male mice underwent stroke induced by permanent occlusion of the distal branches of the middle cerebral artery. Mice were randomly assigned to receive either vehicle dimethyl sulfoxide/PBS (2 mL/kg body weight/day, IP), a novel SPAK inhibitor, 5-chloro-N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxybenzamide (ZT-1a' 5 mg/kg per day, IP) or a NF-κB (nuclear factor-κB) inhibitor TAT-NBD (transactivator of transcription-NEMO-binding domain' 20 mg/kg per day, IP). Activation of brain NF-κB and WNK-SPAK-NKCC1 cascade as well as ischemic stroke outcomes were examined. RESULTS: Stroke triggered a 2- to 5-fold increase of WNK (isoforms 1, 2, 4), SPAK/OSR1 (oxidative stress-responsive kinase 1), and NKCC1 protein in the ang II-infused hypertensive mouse brains at 24 hours after stroke, which was associated with increased nuclear translocation of phospho-NF-κB protein in the cortical neurons (a Pearson correlation r of 0.77, P<0.005). The upregulation of WNK-SPAK-NKCC1 cascade proteins resulted from increased NF-κB recruitment on Wnk1, Wnk2, Wnk4, Spak, and Nkcc1 gene promoters and was attenuated by NF-κB inhibitor TAT-NBD. Poststroke administration of SPAK inhibitor ZT-1a significantly reduced WNK-SPAK-NKCC1 complex activation, brain lesion size, and neurological function deficits in the ang II-hypertensive mice without affecting blood pressure and cerebral blood flow. CONCLUSIONS: The ang II-induced stimulation of NF-κB transcriptional activity upregulates brain WNK-SPAK-NKCC1 cascade and contributes to worsened ischemic stroke outcomes, illustrating the brain WNK-SPAK-NKCC1 complex as a therapeutic target for stroke with comorbid hypertension.
引用
- Bhuiyan MIH, Young CB, Jahan I, et al. NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II-Hypertensive Mice. Stroke. 2022. PMID: 35272484. doi:10.1161/STROKEAHA.121.038351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。